A Covid-19 vaccine developed and tested in Russia generated neutralizing antibodies in dozens of study subjects, and while the vaccine often caused side effects such as fever, those side effects were mostly mild, according to data published Friday in the medical journal The Lancet.
Scientists not involved in the study say only a Phase 3 trial can confirm if the vaccine prevents Covid-19 illness
